Role of Nasya Karma in special type of Headache (Migraine) at the time of Menstrual Cycle

Phase 3

Not yet recruiting

• Conditions: Other specified conditions associated with female genital organs and menstrual cycle,

• Registration Number: CTRI/2020/09/027923
• Lead Sponsor: Mahatma Gandhi Ayurved College Hospital Research Centre Salod Wardha

Brief Summary

Patients fulfilling criteria will be assigned into two groups by computerized randomization chart method group A and group B.

Groups of Patients

Group A (Trial group)

Nasya with *Dashamula ghrita* 8 drops in each nostril once a day in morning hours

For the period of 15 days ( 10 days prior to probable date of Menses + 5 days of Menses)

Group B (Control group )

*Nasya* with *Shadbindu Tail* 8 drops in each nostril once a day in morning hours

For the period of 15 days ( 10 days prior to probable date of Menses + 5 days of Menses)

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-09-18
• Study Start: 2020-09-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

Patients with Specific feature of Menstrual migraine Patient with age from Menarche to Menopause.

Exclusion Criteria

• Sufferer of major disorders like hypertension, diabetes, hypothyroidism, severe anemia, irritable bowel syndrome, etc.
• Patients having Migraine which is not related with Menstruation.
• Patients of irregular menstrual cycle Patients contraindicated for Nasya karma.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effect of Nasya karma will be assessed with frequency of attack of migraine during menstruation. It is recorded as before Treatment (BT) and after Treatment (AT)	12 weeks

Secondary Outcome Measures

Name	Time	Method
The effect of Nasya karma will be assessed regarding the clinical signs and symptoms along with parameters. All subjective and objective parameters will be observed and recorded as before Treatment (BT) and after Treatment (AT)	12 weeks

Trial Locations

Locations (1)

Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha; 🇮🇳 Wardha, MAHARASHTRA, India

Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha

🇮🇳Wardha, MAHARASHTRA, India

Dr Bhagyashri Vijay Chaudhari

Principal investigator

9096415920

dr.bhagyashrichaudhari@gmail.com